Table 3.
Study authors | Q1 | Q2 | Q3 | Q4 | Q5 | Q6 | Q7 | Q8 | Q9 | Q10 | Q11 | Overall risk of bias assessment |
---|---|---|---|---|---|---|---|---|---|---|---|---|
Schramm S et al. [45] | Yes | Yes | No | Yes | Yes | No | Yes | Yes | Yes | No | Yes | Moderate |
Hagen K et al. [36] | Yes | Yes | No | Yes | Yes | No | Yes | Yes | Yes | No | Yes | Moderate |
Schramm SH et al. [52] | Yes | Yes | No | Unclear | Yes | No | No | Yes | Yes | No | Yes | High |
Yoon MS et al. [55] | Yes | Yes | No | Yes | Yes | No | No | Unclear | Yes | Yes | Yes | High |
Schramm SH et al. [58] | Yes | Yes | No | Yes | No | No | Yes | Unclear | Unclear | Unclear | Yes | High |
Q1—Were the two groups similar and recruited from the same population?
Q2—Were the exposures measured similarly to assign people to both exposed and unexposed groups?
Q3—Was the exposure measured in a valid and reliable way?
Q4—Were confounding factors identified?
Q5—Were strategies to deal with confounding factors stated?
Q6—Were the groups/participants free of the outcome at the start of the study (or at the moment of exposure)?
Q7—Were the outcomes measured in a valid and reliable way?
Q8—Was the follow-up time reported and sufficiently long for outcomes to occur?
Q9—Was follow-up complete, and if not, were the reasons for this incomplete follow-up described and explored?
Q10—Were strategies to address incomplete follow-up utilized?
Q11—Was appropriate statistical analysis used?